BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9816261)

  • 1. Cytolysis of tumor cells expressing the Neu/erbB-2, erbB-3, and erbB-4 receptors by genetically targeted naive T lymphocytes.
    Altenschmidt U; Kahl R; Moritz D; Schnierle BS; Gerstmayer B; Wels W; Groner B
    Clin Cancer Res; 1996 Jun; 2(6):1001-8. PubMed ID: 9816261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoptive transfer of in vitro-targeted, activated T lymphocytes results in total tumor regression.
    Altenschmidt U; Klundt E; Groner B
    J Immunol; 1997 Dec; 159(11):5509-15. PubMed ID: 9548491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A spacer region between the single chain antibody- and the CD3 zeta-chain domain of chimeric T cell receptor components is required for efficient ligand binding and signaling activity.
    Moritz D; Groner B
    Gene Ther; 1995 Oct; 2(8):539-46. PubMed ID: 8593604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of T lymphocytes to Neu/HER2-expressing cells using chimeric single chain Fv receptors.
    Stancovski I; Schindler DG; Waks T; Yarden Y; Sela M; Eshhar Z
    J Immunol; 1993 Dec; 151(11):6577-82. PubMed ID: 7902379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles.
    Schnierle BS; Moritz D; Jeschke M; Groner B
    Gene Ther; 1996 Apr; 3(4):334-42. PubMed ID: 8732165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR zeta.
    Annenkov A; Chernajovsky Y
    Gene Ther; 2000 Apr; 7(8):714-22. PubMed ID: 10800096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chimeric T cell receptor N29gamma redirect T lymphocytes response specific to p185HER2 in A murine model of metastatic breast cancer].
    Li SP; Urban FA; Macgregor JN; Hughes DP; McDonagh KT
    Ai Zheng; 2004 Nov; 23(11 Suppl):1370-5. PubMed ID: 15566639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A functional role for CD28 costimulation in tumor recognition by single-chain receptor-modified T cells.
    Moeller M; Haynes NM; Trapani JA; Teng MW; Jackson JT; Tanner JE; Cerutti L; Jane SM; Kershaw MH; Smyth MJ; Darcy PK
    Cancer Gene Ther; 2004 May; 11(5):371-9. PubMed ID: 15060573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes.
    Weijtens ME; Willemsen RA; Hart EH; Bolhuis RL
    Gene Ther; 1998 Sep; 5(9):1195-203. PubMed ID: 9930320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles.
    Reuss S; Biese P; Cosset FL; Takeuchi Y; Uckert W
    Gene Ther; 2007 Apr; 14(7):595-603. PubMed ID: 17235289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant heregulin-Pseudomonas exotoxin fusion proteins: interactions with the heregulin receptors and antitumor activity in vivo.
    Yang D; Kuan CT; Payne J; Kihara A; Murray A; Wang LM; Alimandi M; Pierce JH; Pastan I; Lippman ME
    Clin Cancer Res; 1998 Apr; 4(4):993-1004. PubMed ID: 9563895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redirecting effector T cells through their IL-2 receptors.
    Lustgarten J; Marks J; Sherman LA
    J Immunol; 1999 Jan; 162(1):359-65. PubMed ID: 9886407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric zeta-receptors direct human natural killer (NK) effector function to permit killing of NK-resistant tumor cells and HIV-infected T lymphocytes.
    Tran AC; Zhang D; Byrn R; Roberts MR
    J Immunol; 1995 Jul; 155(2):1000-9. PubMed ID: 7608531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-specific cytolysis by neutrophils and NK cells expressing chimeric immune receptors bearing zeta or gamma signaling domains.
    Roberts MR; Cooke KS; Tran AC; Smith KA; Lin WY; Wang M; Dull TJ; Farson D; Zsebo KM; Finer MH
    J Immunol; 1998 Jul; 161(1):375-84. PubMed ID: 9647246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene-specific inhibition of breast carcinoma in BALB-neuT mice by active immunization with rat Neu or human ErbB receptors.
    Masuelli L; Focaccetti C; Cereda V; Lista F; Vitolo D; Trono P; Gallo P; Amici A; Monaci P; Mattei M; Modesti M; Forni G; Kraus MH; Muraro R; Modesti A; Bei R
    Int J Oncol; 2007 Feb; 30(2):381-92. PubMed ID: 17203220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo properties of three human HER2/neu-expressing murine cell lines in immunocompetent mice.
    Penichet ML; Challita PM; Shin SU; Sampogna SL; Rosenblatt JD; Morrison SL
    Lab Anim Sci; 1999 Apr; 49(2):179-88. PubMed ID: 10331548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice.
    Wei H; Wang S; Zhang D; Hou S; Qian W; Li B; Guo H; Kou G; He J; Wang H; Guo Y
    Clin Cancer Res; 2009 Jul; 15(14):4612-21. PubMed ID: 19584156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-mediated cytolysis of tumor cells: use of heregulin-zeta chimeras to redirect cytotoxic T lymphocytes.
    Muniappan A; Banapour B; Lebkowski J; Talib S
    Cancer Gene Ther; 2000 Jan; 7(1):128-34. PubMed ID: 10678365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bypassing immunization: optimized design of "designer T cells" against carcinoembryonic antigen (CEA)-expressing tumors, and lack of suppression by soluble CEA.
    Nolan KF; Yun CO; Akamatsu Y; Murphy JC; Leung SO; Beecham EJ; Junghans RP
    Clin Cancer Res; 1999 Dec; 5(12):3928-41. PubMed ID: 10632322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive immunotherapy using human peripheral blood lymphocytes transferred with RNA encoding Her-2/neu-specific chimeric immune receptor in ovarian cancer xenograft model.
    Yoon SH; Lee JM; Cho HI; Kim EK; Kim HS; Park MY; Kim TG
    Cancer Gene Ther; 2009 Jun; 16(6):489-97. PubMed ID: 19096447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.